
Number of publications published per year by Borzio, Mauro. (Source : PubMed)

Distribution of publications types for Borzio, Mauro. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Am. J. Gastroenterol.
2009;104;5
Epidemiology and outcome of hepatocellular carcinoma in Lombardy.
Dig Liver Dis
2007;39;11
Hepatocellular dysplastic nodules.
Hepatol. Res.
2007;37 Suppl 2


Triple antiviral therapy in HCV positive patients who failed prior combination therapy.
World J. Gastroenterol.
2006;12;33

Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.
J. Hepatol.
2003;39;2
Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon.
J. Hepatol.
2003;38;4
Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
Hepatology
2003;37;1



Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
Am. J. Gastroenterol.
2002;97;5

Clinical relevance of hepatocyte proliferative activity.
Dig Liver Dis
2002;34;3
Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
Hepatology
2001;34;6
[ See timeline ] [ See all publications ]
means that Borzio, Mauro has 23 papers cited a least 23 times - methodology
Department ofMedicine, Surgery and Dentistry, School of Medicine Ospedale San Paolo, University of Milan, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.